HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population.

AbstractAIMS:
Gamma-glutamyltransferase (GGT) has been recognized as a cardiovascular risk factor, and its highest molecular weight fraction [big GGT (b-GGT)] is found in vulnerable atherosclerotic plaques. We explored the relationship between b-GGT, computed tomography findings, and long-term outcomes in the general population.
METHODS AND RESULTS:
Between May 2010 and October 2011, subjects aged 45-75 years living in a Tuscan city and without known cardiac disease were screened. The primary endpoint was a composite of cardiovascular death or acute coronary syndrome requiring urgent coronary revascularization. Gamma-glutamyltransferase fractions were available in 898 subjects [median age 65 years (25th-75th percentile 55-70), 46% men]. Median plasma GGT was 20 IU (15-29), and b-GGT was 2.28 (1.28-4.17). Coronary artery calcium (CAC) score values were 0 (0-60), and the volume of pro-atherogenic epicardial fat was 155 mL (114-204). In a model including age, sex, low-density lipoprotein (LDL) cholesterol, current or previous smoking status, hypertension, diabetes, obesity, b-GGT independently predicted epicardial fat volume (EFV) (r = 0.162, P < 0.001), but not CAC (P = 0.198). Over a 10.3-year follow-up (9.6-10.8), 27 subjects (3%) experienced the primary endpoint. We evaluated couples of variables including b-GGT and a cardiovascular risk factor, CAC or EFV. Big GGT yielded independent prognostic significance from age, LDL cholesterol, current or previous smoking status, hypertension, diabetes, obesity, but not CAC or EFV. Conversely, GGT predicted the primary endpoint even independently from CAC and EFV.
CONCLUSION:
Big GGT seemed at least as predictive as the commonly available GGT assay; therefore, the need for b-GGT rather than GGT measurement should be carefully examined.
AuthorsAlberto Aimo, Sara Chiappino, Aldo Paolicchi, Daniele Della Latta, Nicola Martini, Alberto Clemente, Veronica Musetti, Silvia Masotti, Giorgia Panichella, Valeria Piagneri, Simona Storti, Angelo Monteleone, Claudio Passino, Dante Chiappino, Maria Franzini, Michele Emdin
JournalEuropean journal of preventive cardiology (Eur J Prev Cardiol) Vol. 29 Issue 11 Pg. 1510-1518 (08 22 2022) ISSN: 2047-4881 [Electronic] England
PMID34928344 (Publication Type: Journal Article)
CopyrightPublished on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: [email protected].
Chemical References
  • gamma-Glutamyltransferase
Topics
  • Male
  • Humans
  • Aged
  • Female
  • Coronary Artery Disease (epidemiology)
  • gamma-Glutamyltransferase
  • Pericardium (diagnostic imaging)
  • Hypertension
  • Obesity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: